Onyvax raises EUR17.5 million

Cancer vaccine developer Onyvax (London, U.K.) raised EUR17.5 million ($15 million) in a private financing through Merlin Biosciences; MB Venture Capital Fund I; 3i; S.R. One; and Alta Berkeley. ...